Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

August 4, 2016 at 9:22 am

Clin Infect Dis. (2016) 63 (4): 433-442

Thomas F. Patterson, George R. Thompson III, David W. Denning, Jay A. Fishman, Susan Hadley, Raoul Herbrecht, Dimitrios P. Kontoyiannis, Kieren A. Marr, Vicki A. Morrison, M. Hong Nguyen, Brahm H. Segal, William J. Steinbach, David A. Stevens, Thomas J. Walsh, John R. Wingard, Jo-Anne H. Young, and John E. Bennett

1University of Texas Health Science Center at San Antonio and South Texas Veterans Health Care System

2University of California, Davis

3National Aspergillosis Centre, University Hospital of South Manchester, University of Manchester, United Kingdom

4Massachusetts General Hospital and Harvard Medical School

5Tufts Medical Center, Boston, Massachusetts

6University of Strasbourg, France

7University of Texas MD Anderson Cancer Center, Houston

8Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland

9Hennepin County Medical Center and University of Minnesota, Minneapolis

10University of Pittsburgh, Pennsylvania

11University at Buffalo Jacobs School of Medicine and Biomedical Sciences, and Roswell Park Cancer Institute, New York

12Duke University Medical Center, Durham, North Carolina

13California Institute for Medical Research, San Jose

14New York–Presbyterian Hospital/Weill Cornell Medical Center, New York

15University of Florida, Gainesville

16University of Minnesota, Minneapolis

17Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient’s individual circumstances.

abstract

http://cid.oxfordjournals.org/content/63/4/e1.abstract?sid=2377ea3f-a5d8-486b-aec1-5549df830d26

PDF

http://cid.oxfordjournals.org/content/63/4/e1.full.pdf+html

Entry filed under: Antimicoticos, Biología Molecular, CONSENSOS, Epidemiología, GUIDELINES, Infecciones micoticas, Metodos diagnosticos, Sepsis, Update. Tags: .

Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture Practice Guidelines for the Diagnosis and Management of Aspergillosis – 2016 Update by the Infectious Diseases Society of America


Calendar

August 2016
M T W T F S S
« Jul   Sep »
1234567
891011121314
15161718192021
22232425262728
293031  

Most Recent Posts


%d bloggers like this: